Biotest Divestiture Trust - Net Worth and Insider Trading
Biotest Divestiture Trust Net Worth
The estimated net worth of Biotest Divestiture Trust is at least $43 Million dollars as of 2024-06-05. Biotest Divestiture Trust is the 10% Owner of ADMA Biologics Inc and owns about 4,295,580 shares of ADMA Biologics Inc (ADMA) stock worth over $43 Million. Details can be seen in Biotest Divestiture Trust's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Biotest Divestiture Trust has not made any transactions after 2019-06-06 and currently still holds the listed stock(s).
Transaction Summary of Biotest Divestiture Trust
Biotest Divestiture Trust Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Biotest Divestiture Trust owns 1 companies in total, including ADMA Biologics Inc (ADMA) .
Click here to see the complete history of Biotest Divestiture Trust’s form 4 insider trades.
Insider Ownership Summary of Biotest Divestiture Trust
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2019-06-06 | 10 percent owner |
Biotest Divestiture Trust Latest Holdings Summary
Biotest Divestiture Trust currently owns a total of 1 stock. Biotest Divestiture Trust owns 4,295,580 shares of ADMA Biologics Inc (ADMA) as of June 6, 2019, with a value of $43 Million.
Latest Holdings of Biotest Divestiture Trust
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2019-06-06 | 4,295,580 | 10.09 | 43,342,402 |
Holding Weightings of Biotest Divestiture Trust
Biotest Divestiture Trust Form 4 Trading Tracker
According to the SEC Form 4 filings, Biotest Divestiture Trust has made a total of 0 transactions in ADMA Biologics Inc (ADMA) over the past 5 years. The most-recent trade in ADMA Biologics Inc is the sale of 5,813,954 shares on June 6, 2019, which brought Biotest Divestiture Trust around $22 Million.
Insider Trading History of Biotest Divestiture Trust
- 1
Biotest Divestiture Trust Trading Performance
Biotest Divestiture Trust Ownership Network
Biotest Divestiture Trust Owned Company Details
What does ADMA Biologics Inc do?
Who are the key executives at ADMA Biologics Inc?
Biotest Divestiture Trust is the 10 percent owner of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
ADMA Biologics Inc (ADMA) Insider Trades Summary
Over the past 18 months, Biotest Divestiture Trust made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 382,769 shares made by Brian Lenz .
In summary, during the past 3 months, insiders sold 1,500,000 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,083,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 3,891,580 shares.
ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ADMA Biologics Inc Insider Transactions
Biotest Divestiture Trust Mailing Address
Above is the net worth, insider trading, and ownership report for Biotest Divestiture Trust. You might contact Biotest Divestiture Trust via mailing address: C/o Eric Rosenbach, Trustee, 402 Norfolk Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
